HealthEquity Inc HQY 深 沪
已收盘 04-02 16:00:00 美东时间
84.67
+1.290
+1.55%
华盛通- 最 高85.085
- 今 开83.22
- 成交量 64.03万股
- 最 低 81.92
- 昨 收 83.38
- 总市值 71.53亿
- 52周最高 116.65
- 市盈率 静 34.42
- 换手率 0.76%
- 52周最低 72.76
- 委 比 -74.52%
- 总股本 8447.84万
- 历史最高 116.65
- 量 比 0.68
- 振 幅 3.80%
- 历史最低 15.80
- 每 手 1
- 风险率 8.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多HealthEquity appoints Sanford Health CEO Bill Gassen to board
HealthEquity appoints Sanford Health CEO Bill Gassen to board HealthEquity elected Sanford Health CEO William “Bill” Gassen to board of directors, effective March 26, 2026. Board expanded to 10 directors, including eight independent directors. Gassen will join Audit and Risk Committee. He will also
03-30 20:34
HealthEquity Appoints Sanford Health CEO Bill Gassen to Board of Directors
HealthEquity, Inc. announced that William 'Bill' Gassen, CEO of Sanford Health, has been elected to its board of directors, effective March 26, 2026. Gassen will also serve on the Audit and Risk Committee and Talent, Compensation and Culture Committee. His appointment expands the Board to 10 directors, eight of whom are independent. Gassen brings extensive experience in healthcare delivery, financing, and addressing challenges in the healthcare s...
03-30 12:30
美股大行评级 | 最高700美元！大摩、瑞银等10家大行集体上调美光目标价；通用磨坊、梅西百货、SailPoint等遭多家大行下调目标价
今日重点评级关注：RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从32美元升至35美元；巴克莱：维持CytomX医疗"超配"评级，目标价从10美元升至16美元
03-20 15:53
美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
RBC Capital Maintains Outperform on HealthEquity, Lowers Price Target to $100
RBC Capital analyst Daniel R. Perlin maintains HealthEquity (NASDAQ:HQY) with a Outperform and lowers the price target from $110 to $100.
03-18 22:18
电话会总结 ｜ HealthEquity(HQY)2026财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据HealthEquity业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **2026财年第四季度业绩表现：** - **营收**：3.346亿美元，同比增长7% - **净利润**：4,970万美元，同比增长93%；净利润率15% - **Non-GAAP净利润**：8,180万美元，同比增长33%；每股收益0.95美元，同比增长38% - **毛利率**：68%，较上年同期61%大幅提升超过700个基点 - **调整后EBITDA**：1.329亿美元，同比增长23%；调整后EBITDA利润率40%，同比扩张超过500个基点 **2
03-18 12:03
财报速睇 | HealthEquity Inc 2026财年Q4营收3.35亿美元，同比增长7.3%；归母净利润0.50亿美元，同比增长88.7%
华盛资讯3月18日讯，HealthEquity Inc公布2026财年Q4业绩，公司Q4营收3.35亿美元，同比增长7.3%，归母净利润0.50亿美元，同比增长88.7%。
03-18 04:32
HealthEquity Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
HealthEquity, Inc. (NASDAQ: HQY) to release Q4 earnings on 3/17. Analysts expect earnings of $0.90/share and revenue of $332.82M. Stock rose 1.1% on 3/16.
03-17 22:08
Earnings Scheduled For March 17, 2026
Companies Reporting Before The Bell • GDS Holdings (NASDAQ:GDS) is expected to ...
03-17 19:11
HealthEquity Q4 2026 Earnings Preview
HealthEquity (HQY) is scheduled to announce Q4 earnings results on Tuesday, March 17th, after market close. The consensus EPS Estimate is $0.90 (+30.4% Y/Y) and the consensus Revenue Estimate is $332....
03-17 05:35
